India's vaccine regulatory body NRAI gets highest WHO ratings

Image
Press Trust of India New Delhi
Last Updated : Feb 17 2017 | 9:22 PM IST
The National Regulatory Authority of India (NRAI) has been given the maximum ratings by global health body World Health Organisation for vaccine regulations.
WHO completed the assessment of the status of the Indian vaccine regulatory system against WHO NRA Global Benchmarking Tool (GBT) and measured the maturity of the system in India.
"The assessment has been done in respect of 9 different functionalities and Indian NRA has been declared 'functional' with a maturity level of 4 which is the highest level as per currently evolved definitions in respect of 5 functions, and maturity level 3 in respect of 4 functions," an official statement said.
While, maturity level 4 indicates good results and sustained improvement trends, level 3 reflects systematic process based approach, early stage of systematic improvements, data availability regarding conformance to objectives and existence of improvement trends, it said.
A fully functional NRA is a pre-requisite for WHO prequalification of vaccines and one of the requirements to become eligible and retain prequalification status is to have the National Regulatory Authority (NRA) assessed as functional against the WHO published NRA indicators.
WHO Prequalification Programme, as such, facilitates access to vaccines that meet the unified standards of quality, safety and efficacy as well as programme needs.
A WHO-led team of international experts from several countries came to this conclusion at the end of comprehensive review from 13-17 February 2017.
"The NRA and affiliated institutions meet WHO Global Benchmarking Tool requirements for a functional vaccine regulatory system," WHO said.
"This is indeed a great achievement and we would like to congratulate the Indian Health Ministry and its affiliated institutions - Central Drugs Standards Control Organization (CDSCO), Central Drugs Laboratory, Kasauli, Pharmacovigilance Programme and Immunization Division, and other relevant institutions engaged in the regulation, control and testing of vaccines," said Alireza Khadem, WHO Team Leader for the NRA Re-benchmarking.
Union Health secretary C K Mishra said India is one of the largest manufacturers and exporters of vaccines world-wide.
"This development further deepens our resolve to maintain the highest quality and efficacy of the products that are manufactured within our country and in this context, we look forward to strengthening our collaboration with WHO," the WHO statement quoting Mishra said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 17 2017 | 9:22 PM IST

Next Story